Manfred Ballmann

5.4k total citations
103 papers, 2.9k citations indexed

About

Manfred Ballmann is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Manfred Ballmann has authored 103 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 25 papers in Surgery and 19 papers in Epidemiology. Recurrent topics in Manfred Ballmann's work include Cystic Fibrosis Research Advances (64 papers), Neonatal Respiratory Health Research (27 papers) and Tracheal and airway disorders (17 papers). Manfred Ballmann is often cited by papers focused on Cystic Fibrosis Research Advances (64 papers), Neonatal Respiratory Health Research (27 papers) and Tracheal and airway disorders (17 papers). Manfred Ballmann collaborates with scholars based in Germany, Netherlands and United States. Manfred Ballmann's co-authors include Sibylle Junge, H. von der Hardt, J. Michael Conlon, Helge Hebestreit, Henk J. Veeze, Inez Bronsveld, Alexandra Hebestreit, Jan Bijman, Matthias Griese and Susi Kriemler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Manfred Ballmann

93 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Manfred Ballmann 2.1k 497 376 348 320 103 2.9k
José Dirceu Ribeiro 1.8k 0.8× 378 0.8× 699 1.9× 443 1.3× 237 0.7× 209 2.8k
Margaret E. Hodson 1.8k 0.8× 282 0.6× 330 0.9× 340 1.0× 623 1.9× 78 2.8k
Micha Aviram 1.4k 0.7× 299 0.6× 298 0.8× 352 1.0× 549 1.7× 56 2.3k
Lea Bentur 2.6k 1.2× 487 1.0× 962 2.6× 680 2.0× 415 1.3× 152 3.8k
David Shoseyov 1.6k 0.7× 295 0.6× 457 1.2× 423 1.2× 484 1.5× 103 2.8k
Harriet Corvol 2.0k 0.9× 314 0.6× 380 1.0× 419 1.2× 721 2.3× 148 3.1k
R Dinwiddie 1.5k 0.7× 413 0.8× 416 1.1× 312 0.9× 146 0.5× 89 2.3k
Alexander Spock 1.6k 0.7× 415 0.8× 297 0.8× 192 0.6× 361 1.1× 69 2.6k
Clement L. Ren 2.3k 1.1× 206 0.4× 296 0.8× 295 0.8× 258 0.8× 112 3.0k
Henry L. Dorkin 1.5k 0.7× 266 0.5× 336 0.9× 320 0.9× 461 1.4× 42 2.5k

Countries citing papers authored by Manfred Ballmann

Since Specialization
Citations

This map shows the geographic impact of Manfred Ballmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Ballmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Ballmann more than expected).

Fields of papers citing papers by Manfred Ballmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Ballmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Ballmann. The network helps show where Manfred Ballmann may publish in the future.

Co-authorship network of co-authors of Manfred Ballmann

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Ballmann. A scholar is included among the top collaborators of Manfred Ballmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Ballmann. Manfred Ballmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welsner, Matthias, et al.. (2024). Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert’s syndrome. BMC Pulmonary Medicine. 24(1). 307–307.
2.
Burgel, Pierre‐Régis, Manfred Ballmann, Pavel Dřevı́nek, et al.. (2024). Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy. BMJ Open Respiratory Research. 11(1). e002049–e002049. 9 indexed citations
3.
Cardesa‐Salzmann, Teresa M., Monika Sparber‐Sauer, Andreas Erbersdobler, et al.. (2024). On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion‐Positive Infantile Fibrosarcoma of the Head and Neck. Head & Neck. 47(5). E50–E57.
4.
Elborn, J.S., Francesco Blasi, Charles Haworth, et al.. (2022). Bronchiectasis and inhaled tobramycin: A literature review. Respiratory Medicine. 192. 106728–106728. 21 indexed citations
5.
Rauscher, Robert, Disha Joshi, Lisa J. Strug, et al.. (2021). Positive epistasis between disease-causing missense mutations and silent polymorphism with effect on mRNA translation velocity. Proceedings of the National Academy of Sciences. 118(4). 23 indexed citations
6.
Seidl, Elias, Gerhard Liebisch, Manfred Ballmann, et al.. (2019). Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis. Journal of Cystic Fibrosis. 18(6). 790–795. 17 indexed citations
7.
Keßler, Anja, et al.. (2019). Exhaled nitric oxide can't replace the methacholine challenge in suspected pediatric asthma. Respiratory Medicine. 157. 21–25.
8.
Kriemler, Susi, Sibylle Junge, Manfred Ballmann, et al.. (2013). Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial. Journal of Cystic Fibrosis. 12(6). 714–720. 63 indexed citations
9.
Stanke, Frauke, Stephanie Tamm, B. Siebert, et al.. (2010). Functional analysis of F508del CFTR in native human colon. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(11). 1062–1069. 26 indexed citations
10.
Danziger‐Isakov, Lara, Sarah Worley, Marian G. Michaels, et al.. (2009). The Risk, Prevention, and Outcome of Cytomegalovirus After Pediatric Lung Transplantation. Transplantation. 87(10). 1541–1548. 47 indexed citations
11.
Stanke, Frauke, Manfred Ballmann, Inez Bronsveld, et al.. (2008). Diversity of the basic defect of homozygous CFTR mutation genotypes in humans. Journal of Medical Genetics. 45(1). 47–54. 30 indexed citations
12.
Hebestreit, Helge, Stefan G. Rüdiger, Thomas Schenk, et al.. (2006). Physical activity is independently related to aerobic capacity in cystic fibrosis. European Respiratory Journal. 28(4). 734–739. 100 indexed citations
13.
Stanke, Frauke, et al.. (2006). Ex vivo biochemical analysis of CFTR in human rectal biopsies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(4). 393–397. 13 indexed citations
14.
Griese, Matthias, Reinhold E. Schmidt, Ernst Rietschel, et al.. (2004). Pulmonary Surfactant, Lung Function, and Endobronchial Inflammation in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 170(9). 1000–1005. 65 indexed citations
15.
Jonge, Hugo R. de, Manfred Ballmann, Henk J. Veeze, et al.. (2004). Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers. Journal of Cystic Fibrosis. 3. 159–163. 65 indexed citations
16.
Paul, K., Ernst Rietschel, Manfred Ballmann, et al.. (2003). Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 169(6). 719–725. 139 indexed citations
17.
Ballmann, Manfred & H. von der Hardt. (2002). Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis. Journal of Cystic Fibrosis. 1(1). 35–37. 57 indexed citations
18.
Mekus, Frauke, et al.. (2000). Categories of ΔF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Research. 3(4). 277–293. 93 indexed citations
19.
Maurin, N. & Manfred Ballmann. (1988). Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.. PubMed. 30(1). 35–41. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Dirceu Ribeiro Breakdown of academic impact, for papers by Margaret E. Hodson Breakdown of academic impact, for papers by Micha Aviram Breakdown of academic impact, for papers by Lea Bentur Breakdown of academic impact, for papers by David Shoseyov Breakdown of academic impact, for papers by Harriet Corvol Breakdown of academic impact, for papers by R Dinwiddie Breakdown of academic impact, for papers by Alexander Spock Breakdown of academic impact, for papers by Clement L. Ren Breakdown of academic impact, for papers by Henry L. Dorkin
Rankless by CCL
2026